




Searching News Database: XL184
HSMN NewsFeed - 10 Jan 2011
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
HSMN NewsFeed - 12 Dec 2008
Bristol-Myers Squibb and Exelixis Enter Global Collaboration on Two Novel Cancer Programs
Bristol-Myers Squibb and Exelixis Enter Global Collaboration on Two Novel Cancer Programs
HSMN NewsFeed - 26 Jun 2006
Exelixis Appoints Experienced Biotechnology Executive as Chief Medical Officer
Exelixis Appoints Experienced Biotechnology Executive as Chief Medical Officer
Additional items found! 14

Members Archive contains
14 additional stories matching:
XL184
(Password required)
XL184
(Password required)